The authors reply

New England Journal of Medicine

Volumn 369, Issue 15, 2013, Pages 1472-

  Lo Coco, Francesco ^a   Orlando, Sonia M ^b   Platzbecker, Uwe ^c  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b GIMEMA Data Center   (Italy)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ORGANOARSENIC DERIVATIVE; OXIDE; RETINOIC ACID;

FEMALE; HUMAN; MALE; NOTE; PROMYELOCYTIC LEUKEMIA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARSENICALS; FEMALE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; OXIDES; TRETINOIN;

EID: 84885629467     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1309895     Document Type: Letter

References (3)

1. F Lo-Coco G Avvisati M Vignetti Retinoic acid and arsenic trioxide for acute promyelocytic leukemia N Engl J Med 369 2013 111 121
2. JH Park B Qiao KS Panageas Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid Blood 118 2011 1248 1254
3. L Ades A Guerci E Raffoux Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience Blood 115 2010 1690 1696